TECOS: A Phase III, Randomized, Placebo Controlled Clinical Trial to Evaluate Cardiovascular Outcomes after Treatment with Sitagliptin in Patients with Type 2 Diabetes Mellitus
Awarded By
- Merck
Contributors
- Green, Jennifer Brigitte Investigator and Clinical Lead: Duke Clinical Research Institute Co-Chair: TECOS Operations Committee Chair: TECOS Clinical Events Committee
Start/End
- 2008